Market Place
Sourcing Support
All News #Library
Biotech
Geron To Unveil Q1 2026 Financial Results On May 6
22 Apr 2026 //
GLOBENEWSWIRE
Geron Joins 25th Annual Needham Healthcare Conference
06 Apr 2026 //
GLOBENEWSWIRE
Geron Announces Appointment of Members to its Board of Directors
26 Mar 2026 //
GLOBENEWSWIRE
Geron To Unveil Q4 And Full Year 2025 Financials On Feb 25, 2026
11 Feb 2026 //
GLOBENEWSWIRE
Geron Unveils ASH 2025 Data Linking Cytopenias To RYTELO
08 Dec 2025 //
GLOBENEWSWIRE
Geron Corp. Reveals Q3 2025 Financials & Business Updates
05 Nov 2025 //
BUSINESSWIRE
Geron Corp. Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
20 Oct 2025 //
BUSINESS WIRE
Geron Corp Reveals Executive Leadership Changes
13 Oct 2025 //
GLOBENEWSWIRE
Geron Presents RYTELO® Efficacy and Safety at ASCO and EHA
28 May 2025 //
BUSINESSWIRE
Geron`s RYTELO™ Approved By CHMP For Transfusion-Dependent MDS
13 Dec 2024 //
BUSINESSWIRE
Geron: IMerge Data Shows RYTELO™ Active In Lower-Risk MDS
10 Dec 2024 //
BUSINESSWIRE
Geron to Present RYTELO™ Data at ASH in Hematologic Malignancies
05 Nov 2024 //
BUSINESSWIRE
Geron Announces 50% Enrollment in the Phase 3 Trial Evaluating Imetelstat
06 Dec 2023 //
BUSINESSWIRE
Geron Announces Publication of Results from Phase 3 Evaluating Imetelstat
04 Dec 2023 //
BUSINESSWIRE
Geron IMerge Phase 3 Presentations Reinforce Durability of Imetelstat
02 Nov 2023 //
BUSINESSWIRE
Geron Announces EMA Validation of MAA for Imetelstat
29 Sep 2023 //
BUSINESSWIRE
Geron Announces Data Presentations from IMerge Phase 3 Evaluating Imetelstat
07 Sep 2023 //
BUSINESSWIRE
Geron Announces FDA Acceptance of New Drug Application for Imetelstat
21 Aug 2023 //
BUSINESSWIRE
Geron Announces First Patient Dosed in PII IMpress Trial Evaluating Imetelstat
13 Jun 2023 //
BUSINESSWIRE
Geron Announces PositiveResults from IMerge Phase 3 Trial of Imetelstat
04 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.